Apixaban PK pecularities [PK / PD]

posted by BE-proff – 2022-03-14 21:17 (933 d 23:03 ago) – Posting: # 22836
Views: 2,404

Hi All,

According to Apixaban PIL its kinetics has some peculiarities::lookaround:

1) AUC is 32% higher in patients aged over 65
2) AUC is 18% higher in women
3) AUC is 30% higher in patients with body weight below 50 kilos.

Will it be correct to say (using extrapolation) that if a slim woman aged 70 takes 2.5 mg of apixaban the "actual dose" is close to 5.0 mg? :confused:

From the point of safety the question is important :wink:

Complete thread:

UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,655 registered users;
71 visitors (0 registered, 71 guests [including 7 identified bots]).
Forum time: 21:21 CEST (Europe/Vienna)

The epistemological value of probability theory is based on the fact
that chance phenomena, considered collectively and on a grand scale,
create non-random regularity.    Andrey Kolmogorov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5